HIGHLIGHTS
- who: Judith C. Sluimer from the Sichuan University, China have published the Article: Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis, in the Journal: (JOURNAL)
- what: This study assessed the effect of partial myeloid Pfkfb3 disruption on atherosclerosis in_vivo, after 12 weeks of HCD. Here, the authors show that partially decreased PFKFB3-mediated glycolysis in monocytes, macrophages and granulocytes does not affect atherogenesis. The authors show that the model does not induce Pfkfb3 knockdown in DCs. It should be noted that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.